<?xml version="1.0" encoding="UTF-8"?>
<p id="Par59">At 6 and 12 months, clinical evaluation, 2D echocardiogram and blood tests were repeated. Moreover, SPECT and CPET were also evaluated at 6 months. Adverse events (AE), serious adverse events (SAE) and major adverse cardiac events (MACE) were continuously evaluated up to 12 months.</p>
